《盈警响号》兴科蓉医药(06833.HK)开支增加料全年纯利跌39.6%

阿斯达克财经03-14

兴科蓉医药(06833.HK) 发盈警，预计2023年度纯利约4,200万人民币，较上年度减少2,750万人民币或39.6%。主要因集团扩大医美药物研究及制造分部以及医美分部的业务营运导致行政开支增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/29末期业绩普通股息：港元 0.00982022/09/01中期业绩无派息...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2419632107?lang=zh_CN&edition=full","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230801172145032_s.jpg","is_english":false,"pubTime":"2024-03-14 00:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2419632107","market":"fut","top_or_hot":-1,"title":"《盈警响号》兴科蓉医药(06833.HK)开支增加  料全年纯利跌39.6%","media":"阿斯达克财经","content":"<div>\n<p>兴科蓉医药(06833.HK) 发盈警，预计2023年度纯利约4,200万人民币，较上年度减少2,750万人民币或39.6%。主要因集团扩大医美药物研究及制造分部以及医美分部的业务营运导致行政开支增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/29末期业绩普通股息：港元 0.00982022/09/01中期业绩无派息...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333201/latest-news/AAFN\">网页链接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《盈警响号》兴科蓉医药(06833.HK)开支增加  料全年纯利跌39.6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《盈警响号》兴科蓉医药(06833.HK)开支增加  料全年纯利跌39.6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-14 00:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333201/latest-news/AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>兴科蓉医药(06833.HK) 发盈警，预计2023年度纯利约4,200万人民币，较上年度减少2,750万人民币或39.6%。主要因集团扩大医美药物研究及制造分部以及医美分部的业务营运导致行政开支增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/29末期业绩普通股息：港元 0.00982022/09/01中期业绩无派息...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333201/latest-news/AAFN\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06833","symbol_name":"兴科蓉医药","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333201/latest-news/AAFN","article_id":"2419632107","we_media_id":null,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230801172145032_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2419632107","pubTimestamp":1710347640,"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"兴科蓉医药(06833.HK) 发盈警，预计2023年度纯利约4,200万人民币，较上年度减少2,750万人民币或39.6%。主要因集团扩大医美药物研究及制造分部以及医美分部的业务营运导致行政开支增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/29末期业绩普通股息：港元 0.00982022/09/01中期业绩无派息 2022/03/31末期业绩无派息 AASTOCKS新闻","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06833":"兴科蓉医药","BK1197":"保健护理产品经销商"},"translate_title":"[Ying Jing Sheng Hao] Xingkerong Medicine (06833. HK) is expected to increase its annual net profit by 39.6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06833":1},"content_text":"兴科蓉医药(06833.HK) 发盈警，预计2023年度纯利约4,200万人民币，较上年度减少2,750万人民币或39.6%。主要因集团扩大医美药物研究及制造分部以及医美分部的业务营运导致行政开支增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/29末期业绩普通股息：港元 0.00982022/09/01中期业绩无派息 2022/03/31末期业绩无派息 AASTOCKS新闻","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2419632107"}

《盈警响号》兴科蓉医药(06833.HK)开支增加 料全年纯利跌39.6%

精彩评论

《盈警响号》兴科蓉医药(06833.HK)开支增加料全年纯利跌39.6%